p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children

Pediatric and Developmental Pathology

Volumn 2, Issue 4, 1999, Pages 377-384

  Liapis, Helen ^a   Marley, Edith F ^a   Lin, Yuan ^a   Dehner, Louis P ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Malignant peripheral nerve sheath tumor; Neurofibroma; Neurofibromatosis; p53

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; MALIGNANT NEURILEMOMA; MALIGNANT TRANSFORMATION; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; MALE; NERVE SHEATH NEOPLASMS; NEUROFIBROMA; NEUROFIBROMATOSES; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032963486     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249900138     Document Type: Article

References (27)

1. Dehner LP. Some general considerations about the clinicopathologic aspects of soft tissue tumors. In: Coffin CM, Dehner LP, O'Shea PA, eds. Pediatric Soft Tissue Tumors. Baltimore: Williams & Wilkins, 1997;1-14.
2. Coffin CM, Dehner LP. Neurogenic tumors of soft tissues. In: Coffin CM, Dehner LP, O'Shea PA, eds. Pediatric Soft Tissue Tumors. Baltimore: Williams & Wilkins, 1997;80-132.
3. Swanson PE, Scheithauer BW, Wick MR. Peripheral nerve sheath neoplasms. Clinicopathologic and immunohistochemical observations. Pathol Annu 1995;30(Pt 2):1-82.
4. Enzinger FM, Weiss SW. Soft Tissue Tumors, 3rd ed. St. Louis: Mosby, 1995.
5. Wurl P, Taubert H, Meye A, et al. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies. J Cancer Res Clin Oncol 1997;123:502-508.
6. Schneider-Stock R, Radig K, Oda Y, et al. p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy. J Cancer Res Clin Oncol 1997;123:211-218.
7. Nakanishi H, Ohsawa M, Naka N, Uchida A, Ochi T, Aozasa K. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis. Oncology 1997;54:238-244.
8. Benchimos S, Lamb P, Crawford LV, et al. Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somat Cell Mol Genet 1985;11:505-509.
9. Jacks T, Weinberg RA. Cell-cycle control and its watchman. Nature 1996;381:643-644.
10. Momand J, Zambetti GP. Mdm-2 "big brother" of p53. J Cell Biochem 1997;64:343-352.
11. Baas IO, Mulder JWR, Offerhaus JA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
12. Humphrey PA. p53: mutations and immunohistochemical detections, with a focus on alterations in urologic malignancies. Adv Pathol Lab Med 1994;7:579-606.
13. Andreassen A, Oyjord T, Hovig E, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res 1993;53:468-471.
14. Hung J, Anderson R. p53: functions, mutations and sarcomas. Acta Orthop Scand 1997;68 (Suppl 273):68-73.
15. Mousses S, McAuley L, Bell RS, Kandel R, Andrulis IL. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol 1996;9:1-6.
16. Kusafuka T, Fukuzawa M, Oue T, Komoto Y, Yoneda A, Okada A. Mutation analysis of p53 gene in childhood malignant solid tumors. J Pediatr Surg 1997;32:1175-1180.
17. Evans SC, Lozano G. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Mol Med Today 1997;3: 290-395.
18. Wang J, Coltrera MD, Gown AM. Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade. Mod Pathol 1995;8:837-842.
19. Hailing KC, Scheithauer BW, Hailing AC, et al. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor: an immunohistochemical study of sporadic and NF1 associated tumors. Am J Clin Pathol 1996;106:282-288.
20. Kindblom L-G, Ahlden M, Meis-Kindblom JM, Stenman G. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch 1995;427:19-26.
21. Ponder BA. Neurofibromatosis: from gene to phenotype. Semin Cancer Biol 1992;3:115-120.
22. Kawai A, Noguchi M, Beppu Y, et al. Nuclear immunoreactivity of p53 protein in soft tissue sarcomas: a possible prognostic factor. Cancer 1994;73:2499-2505.
23. Crispino S, Brenna A, Colombo D, et al. Ki-67 labeling index in breast cancer. Tumori 1989;75:557-562.
24. Lin BT-Y, Weiss LM, Medeiros LJ. Neurofibroma and cellular neurofibroma with atypia. A report of 14 cases. Am J Surg Pathol 1997;21:1443-1449.
25. Coffin CM, Dehner LP. Cellular peripheral neural tumors (neurofibromas) in children and adolescents: a clinicopathological and immunohistochemical study. Pediatr Pathol 1990;10:345-361.
26. Rogel A, Popliker M, Webb C, Oren M. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 1985;5:2851-2855.
27. MacGeoch C, Barnes DM, Newton FA, et al. p53 protein detected by immunohistochemical staining is not always mutant. Dis Markers 1993;11:259-260.